CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

A regional cancer center experience of neuroendocrine tumors: clinico-epidemiological profile and treatment outcomes

Author: 
Dr. Smitha C. Saldanha, Dr. Lokanatha D., Dr. Linu Jacob Abraham, Dr. Suresh Babu, M C., Dr. Lokesh K. N., Dr. Rudresha, A. H. and Dr. Rajeev L.K. and Dr. Premalatha, C.S.
Subject Area: 
Health Sciences
Abstract: 

Background: Neuro Endocrine Tumors (NET) comprises a family of neoplasms derived from the diffuse neuroendocrine system, with a wide range of morphologic, functional and behavioral characteristics. NETs are very uncommon and studies on their clinical profile, management and outcomes are very rare. This study was undertaken to document the clinico-epidemiological profile and outcomes of NETs presenting to a regional cancer centre in South India. Materials and Methods: From a retrospective records review, 252 patients with NET presenting to the Kidwai Memorial Institute of Oncology, Bangalore. The tumor location, clinical symptoms, stage at presentation, sites of metastasis, grading, and modalities of treatment received and their outcomes were studied. Results: The mean age was 53.74 years (± 13.97) (range 19- 85 years) and male: female ratio was 1.6:1. The most common site of presentation was foregut (49.5%), followed by bronchus and lung (17.58%). Among the NETs arising in gastrointestinal tract, esophageal NETs (23.6%) were the most common. Among the oesophageal NETs, nearly 80 % of tumors were located in the lower third of esophagus and gastro-esophageal junction. Metastases seen in 51% of cases, with the majority in liver. Nearly 10% were secretory NETs. Serum Chromogranin levels performed in 10 patients showed a median of 765ng/ml (range 56-2550 ng/ml). Over 70% were classified as poorly differentiated tumors. Nearly 51% received chemotherapy, with 35% receiving cisplatin + etoposide. Almost 15% underwent surgery and 14% received concurrent chemo radiotherapy. Progressive disease was seen in 11% treated cases. The overall survival in the treated cases was 11.25 months for the localized NETs and 4.75 months for the metastatic NETs. Conclusion: NECs occurred more commonly in males and in the foregut, mostly in the lower third of the oesophagus. Metastases were seen in over half the cases, with a large proportion of cases treated with chemotherapy and performed well with intervention.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran